SCNTP™ · the record the programme builds on

The Legacy of Somatic Cell Nuclear Transfer

The short answer. The legacy of somatic cell nuclear transfer is a sixty-four-year arc of verified firsts — Gurdon's frog in 1962[1], Dolly the sheep in 1997[2], induced pluripotent stem cells in 2006–2007[7][8], the Nobel Prize of 2012[18], human nuclear-transfer stem-cell lines in 2013[11], cloned primates in 2018[15], and an endangered horse cloned from decades-frozen cells in 2025[17]. It is equally a legacy of hard lessons — a fabrication scandal, a telomere scare, stubbornly low efficiencies — that made the field measure itself. The SCNTP™ programme inherits both halves.

The arc, briefly

  • 1962 · Oxford

    John Gurdon transfers the nucleus of an adult tadpole intestinal cell into an enucleated frog egg, and the egg develops — the first proof that a specialized cell still carries the whole instruction set.[1]

  • 1996–1997 · Roslin, Scotland

    An adult sheep's mammary-cell nucleus directs the development of Dolly, the first mammal cloned from an adult cell.[2]

  • 1999 → 2016 · the ageing question

    Cloned sheep are reported with shortened telomeres — the chromosome caps tied to cellular ageing — and the field asks whether a reset nucleus keeps its donor's years.[3] Seventeen years on, thirteen aged cloned sheep are found ageing healthily: the reset, when it works, is real.[4]

  • 2004–2006 · Seoul

    Two papers claim human stem-cell lines from cloned blastocysts — the most celebrated result the field had seen. Both are retracted in January 2006; the data were fabricated.[5][6]

  • 2006–2007 · Kyoto and Madison

    Four transcription factors — Oct3/4, Sox2, Klf4, c-Myc — reprogram mouse fibroblasts to pluripotency[7], then human cells[8], with a second group reaching human iPSCs within weeks by a different factor set.[9] Reprogramming no longer needs an egg.

  • 2007 · Oregon

    The first primate embryonic stem-cell lines are derived by SCNT, from rhesus macaques, with DNA analysis confirming the nuclear genome came from the donor skin cell.[10]

  • 2012 · Stockholm

    The Nobel Prize in Physiology or Medicine goes to Gurdon and Yamanaka, "for the discovery that mature cells can be reprogrammed to become pluripotent."[18]

  • 2013–2014 · the human result

    Human embryonic stem-cell lines are derived by SCNT — from as few as two oocytes in some experiments.[11] Within a year the feat is repeated with adult donors aged 35 and 75[12] and with nuclei from a woman with type 1 diabetes.[13]

  • 2017 · Kobe

    A patient receives retinal cells grown from her own iPSCs — the first human transplant of cells made by reprogramming.[14]

  • 2018 · Shanghai

    Zhong Zhong and Hua Hua, two long-tailed macaques, become the first cloned primates, after a histone-demethylase treatment lifts the epigenetic barriers that had blocked primate cloning for two decades.[15]

  • 2025 · conservation cloning

    Two healthy Przewalski's horse foals are born from cells cryopreserved from a stallion who died in 1998 — genetic variation recovered from a freezer for a species that nearly vanished.[17]

  • 2026 · field status

    No SCNT-derived cell therapy has regulatory approval anywhere in the world as of September 2026; clinical translation so far runs mainly through iPSC-derived cells.[14][16]

What the legacy teaches

Proof over promise

The Hwang affair cost the field its naivety. After the 2006 retractions, independent DNA fingerprinting of every claimed line became the norm — visible in every genuine human SCNT paper since.[5][6][10][11] The lesson outlasted the scandal: results in this field are believed when they are measured.

The reset can be real

Dolly's shortened telomeres were read as a warning that clones inherit their donor's age.[3] Larger, later work on aged cloned sheep showed healthy ageing instead — the question taught the field to measure, not assume.[4]

Efficiency stays the bottleneck

In the 2018 primate study, fetal-cell SCNT produced six pregnancies in 21 surrogates and two healthy infants; adult-cell SCNT produced none that survived long.[15] Reviews written a quarter-century after Dolly still describe offspring rates as limited.[16] Anyone quoting a figure near certain success for this technology is not quoting the literature.

Governance is part of the record

The World Health Assembly resolved in 1997 and 1998 that cloning for the replication of human individuals is ethically unacceptable — while leaving the door open to research on cloning's medical promise.[19] Therapeutic research under oversight is the road the field has travelled since.

Where the SCNTP™ programme stands in this legacy

The programme's premise comes straight from this record: the science of resetting cells is done; the economics are not. Oocytes are scarce, micromanipulation is artisanal, and efficiencies stay in single digits.[15][16] SCNTP™ — the Somatic Cell Nuclear Transfer Protocol — is Panacea Bio Chem's research programme on that cost problem: protocol design, peptide and formulation technology, and preservation engineering aimed at patient-matched pluripotent cells that ordinary people can reach. It is a direction of work, stated as such.

The programme is led by Bogdan Dicoias, biochemist and inventor — Director of Panacea Bio Chem Ltd and Scientific Director at Biogenther, his Dominican Republic company, through which he is directly involved in this field: biogenther.com. SCNTP™ is a proprietary Panacea Bio Chem programme developed and invented by Bogdan Dicoias. Its parameters are not publicly disclosed.

The full scientific essay — mechanism, evidence by class, the field's open questions, and the complete reference set — lives on the SCNTP™ homepage.

References

  1. Gurdon JB. The developmental capacity of nuclei taken from intestinal epithelium cells of feeding tadpoles. J Embryol Exp Morphol. 1962 Dec;10:622-40. PMID 13951335Established · animal
  2. Wilmut I, Schnieke AE, McWhir J, Kind AJ, Campbell KH. Viable offspring derived from fetal and adult mammalian cells. Nature. 1997;385(6619):810-3. PMID 9039911 · DOI 10.1038/385810a0Established · animal
  3. Shiels PG, Kind AJ, Campbell KH, et al. Analysis of telomere lengths in cloned sheep. Nature. 1999;399(6734):316-7. PMID 10360570Animal evidence
  4. Sinclair KD, Corr SA, Gutierrez CG, et al. Healthy ageing of cloned sheep. Nat Commun. 2016;7:12359. PMID 27459299Animal evidence
  5. Hwang WS, Ryu YJ, Park JH, et al. Evidence of a pluripotent human embryonic stem cell line derived from a cloned blastocyst. Science. 2004;303(5664):1669-74. Retracted January 2006. PMID 14963337Retracted · the field's lesson
  6. Hwang WS, Roh SI, Lee BC, et al. Patient-specific embryonic stem cells derived from human SCNT blastocysts. Science. 2005;308(5729):1777-83. Retracted January 2006. PMID 15905366Retracted · the field's lesson
  7. Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell. 2006;126(4):663-76. PMID 16904174Established · animal/in vitro
  8. Takahashi K, Tanabe K, Ohnuki M, et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell. 2007;131(5):861-72. PMID 18035408Established · human cells in vitro
  9. Yu J, Vodyanik MA, Smuga-Otto K, et al. Induced pluripotent stem cell lines derived from human somatic cells. Science. 2007;318(5858):1917-20. PMID 18029452Established · human cells in vitro
  10. Byrne JA, Pedersen DA, Clepper LL, et al. Producing primate embryonic stem cells by somatic cell nuclear transfer. Nature. 2007;450(7169):497-502. PMID 18004281Animal · primate
  11. Tachibana M, Amato P, Sparman M, et al. Human embryonic stem cells derived by somatic cell nuclear transfer. Cell. 2013;153(6):1228-38. PMID 23683578Human cells · in vitro
  12. Chung YG, Eum JH, Lee JE, et al. Human somatic cell nuclear transfer using adult cells. Cell Stem Cell. 2014;14(6):777-80. PMID 24746675Human cells · in vitro
  13. Yamada M, Johannesson B, Sagi I, et al. Human oocytes reprogram adult somatic nuclei of a type 1 diabetic to diploid pluripotent stem cells. Nature. 2014;510(7506):533-6. PMID 24776804Human cells · in vitro
  14. Mandai M, Watanabe A, Kurimoto Y, et al. Autologous induced stem-cell-derived retinal cells for macular degeneration. N Engl J Med. 2017;376(11):1038-1046. PMID 28296613 · DOI 10.1056/NEJMoa1608368Human evidence · iPSC
  15. Liu Z, Cai Y, Wang Y, et al. Cloning of macaque monkeys by somatic cell nuclear transfer. Cell. 2018;172(4):881-887.e7. PMID 29395327Animal · primate
  16. Loi P, Palazzese L, Scapolo PA, Fulka J, Fulka H, Czernik M. 25th anniversary of cloning by somatic-cell nuclear transfer. Reproduction. 2021;162(1):F33-F43. PMID 33666564Review
  17. Novak BJ, Ryder OA, Houck ML, et al. Endangered Przewalski's horse, Equus przewalskii, cloned from historically cryopreserved cells. Animals (Basel). 2025;15(5):613. PMID 40075896 · DOI 10.3390/ani15050613Animal · conservation
  18. The Nobel Prize in Physiology or Medicine 2012: Sir John B. Gurdon and Shinya Yamanaka, "for the discovery that mature cells can be reprogrammed to become pluripotent." nobelprize.orgAward record
  19. World Health Assembly. Ethical, scientific and social implications of cloning in human health — resolutions of 1997 and 1998. World Health Organization, Geneva. WHO IRIS 10665/79553 · WHO IRIS 10665/79804Governance

Concept and programme direction: Bogdan Dicoias, biochemist and inventor. Published by Panacea Bio Chem Scientific Communications. All identifiers on this page were verified against PubMed, Crossref, the Nobel Prize record, and WHO IRIS on 11 September 2026. Nothing here is medical advice.